Fulvestrant
USP/1286650 - United States Pharmacopeia (USP) Reference Standard
Synonym: (7α,17β)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol; Faslodex; ICI 182,780; ZD 182780; ZD 9238; ZM 182780
CAS Number: 129453-61-8
Empirical Formula (Hill Notation): C32H47F5O3S
Molecular Weight: 606.77
MDL Number: MFCD00903953
Linear Formula: C32H47F5O3S
Product Type: Chemical
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C32H47F5O3S/c1-30-17-1 |
InChI key | VWUXBMIQPBEWFH-WCCTWKNTSA |
manufacturer/tradename | USP |
SMILES string | [H][C@]12CC[C@]3(C)[C@@H] |
storage temp. | 2-8°C |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: |
|
Biochem/physiol Actions: | Fulvestrant (ICI 182,780) is a selective estrogen receptor down-regulator (SERD). Fulvestrant is a high affinity estrogen receptor antagonist. IC50 = 0.29 nM. Fulvestrant is the first "pure" antiestrogen with no agonistic activity both in vitro and in vivo. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia ![]() ![]() |
Other Notes: | Sales restrictions may apply. |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-8°C |
UNSPSC | 41116107 |